Examining IBS-C Therapies: A Look at Mechanism, Efficacy, and Safety Profiles
GI InsightsExamining IBS-C Therapies: A Look at Mechanism, Efficacy, and Safety Profiles
Colorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
Clinician's RoundtableColorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
Cost Considerations for Colorectal Cancer Screening: Examining the Data
Clinician's RoundtableCost Considerations for Colorectal Cancer Screening: Examining the Data
Topical Hemostatic Agents in Endoscopy: A Review of Best Practices and Considerations
GI InsightsTopical Hemostatic Agents in Endoscopy: A Review of Best Practices and Considerations
Addressing Barriers to Colorectal Cancer Screening in Rural Populations
Clinician's RoundtableAddressing Barriers to Colorectal Cancer Screening in Rural Populations
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
Clinician's RoundtableWeighing the Environmental Impact of Colorectal Cancer Screening Methods
Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
CME/CE Live BroadcastInnovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
May 04, 2025
09:30 PM - 10:30 PM ET
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
MinuteCE®Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
MinuteCE®The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
Managing Occasional Constipation: The Role of PEG 3350
Medical Industry FeatureManaging Occasional Constipation: The Role of PEG 3350
Objective Measures and Endoscopic Improvement
Medical Industry FeatureObjective Measures and Endoscopic Improvement
Emerging Biomarker Landscape in Gastro/Gastroesophageal Cancer
Medical Industry FeatureEmerging Biomarker Landscape in Gastro/Gastroesophageal Cancer
- 05/02/2025
- 05/01/2025
- 05/01/2025
- 04/30/2025
- 04/28/2025
- 04/24/2025